Table 1. ZIKV-specific neutralizing antibody titers.
Balb/c mice received a single immunization with 50 µg of various DNA vaccines (Fig. 1–2) or 1 µg purified inactivated virus (PIV) vaccines with alum (Fig. 4), and pooled serum was assessed for ZIKV-specific neutralizing antibodies at week 4. 50% microneutralization (MN50) titers are shown. Also shown are MN50 titers in serum from mice following two immunizations with DNA-prM-Env (boost) and an anti-flavivirus human polyclonal antibody.
Vaccine | ZIKV MN50 Titer |
---|---|
DNA-prM-Env | 22 |
DNA-prM-Env.dTM | <10 |
DNA-prM-Env.dStem | <10 |
DNA-Env | <10 |
DNA-Env.dTM | <10 |
DNA-Env.dStem | <10 |
DNA-prM-Env (boost) | 1,022 |
PIV/alum i.m. | 15 |
PIV/alum s.q. | 15 |
Sham/alum i.m. | <10 |
Sham/alum s.q. | <10 |
Anti-flavivirus Ab | 232 |